Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use hydrocodone bitartrate and homatropine methylbromide safely and effectively. See full prescribing information for hydrocodone bitartrate and homatropine methylbromide. Hydrocodone bitartrate and homatropine methylbromide oral solution, CII Initial U.S. Approval: 1943
Medication labelWhy this: Advisory · dailymed-prescription
Hydrocodone bitartrate and homatropine methylbromide is indicated for the symptomatic relief of cough in adult patients 18 years of age and older. Limitations of Use: Not indicated for pediatric patients under 18 years of age [see Use in Specific Populations (8.4)]. Contraindicated in pediatric patients less than 6 years of age [see Contraindications (4)]. Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration, and persist over the course of therapy [see Warnings and Precautions (5.1)], reserve hydrocodone bitartrate and homatropine methylbromide for use in adult patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of cough.
- generic_name
- hydrocodone bitartrate and homatropine methylbromide
- product_names
- Hydrocodone Bitartrate and Homatropine Methylbromide
- ndc
- 0121-1036, 0121-1036-05, 0121-1036-40
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en